https://www.selleckchem.com/pr....oducts/hydroxyfasudi
83 [95% CI, 1.88-7.80], = 0%). Neither pENE nor rENE was associated with locoregional recurrence (pENE HR, 0.75 [95% CI, 0.20-2.84], = 0%; rENE HR, 2.03 [95% CI, 0.86-4.79], = 0%). pENE was not associated with disease-specific survival (pENE HR, 1.45 [95% CI, 0.84-2.49], = 0%). pENE and rENE are moderately associated with an increased risk of all-cause mortality and recurrence with distant metastasis in a cohort of patients with HPV+ OPSCC. These findings may be used to inform exclusion criteria for deintensification tria
Like
Comment
Share
